v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Cash and Cash Equivalent $ 11 $ 11
Trade (net of allowance for doubtful receivables 2025: $-; 2024: $-) 20 16
Accounts Receivable from Related Companies 761 846
Other 24 18
Income taxes receivable 6 42
Notes receivable from related companies 242 593
Inventories 290 296
Other current assets 25 31
Total current assets 1,379 1,853
Investments in related companies 237 237
Other investments 12 12
Noncurrent receivables 32 31
Noncurrent receivables from related companies 1,702 1,642
Total investments 1,983 1,922
Property 5,848 5,732
Less accumulated depreciation 4,706 4,611
Net property 1,142 1,121
Intangible assets (net of accumulated amortization 2025: $96; 2024: $95) 5 6
Operating lease right-of-use assets 58 61
Deferred Tax Assets, Deferred Income 260 253
Deferred charges and other assets 17 17
Total other assets 340 337
Total Assets 4,844 5,233
Notes payable to related companies 17 19
Long-term debt due within one year 1 126
Trade 246 336
Accounts Payable to Related Company 717 470
Other 22 30
Operating lease liabilities - current 12 12
Income taxes payable 37 21
Asbestos-related liabilities - current 81 78
Accrued and other current liabilities 146 136
Total current liabilities 1,279 1,228
Long-Term Debt 142 143
Pension and other postretirement benefits - noncurrent 374 402
Asbestos-related liabilities - noncurrent 645 713
Operating lease liabilities - noncurrent 46 49
Other noncurrent obligations 244 512
Liabilities, Other than Long-term Debt, Noncurrent 1,309 1,676
Common stock (authorized: 1,000 shares of $0.01 par value each; issued: 935.51 shares) 0 0
Additional paid-in capital 1,034 1,034
Retained earnings 2,393 2,496
Accumulated other comprehensive loss (1,313) (1,344)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2,114 2,186
Total Liabilities and Equity $ 4,844 $ 5,233